Passing the ABOM exam is a focused project, not a fellowship. The exam concentrates 97% of its scoring in two clinical domains, so a practicing physician can be ready in about eight weeks of part-time study. Here is the plan, built around the October test date.
Unlock 600 ABOM practice questions across 3 full-length simulators — $19.99 lifetime →
What does the ABOM exam actually reward?
Clinical judgment at a steady pace. You face 200 questions in four one-hour blocks of 50 — about 72 seconds each — weighted 60% Treating Patients with Obesity, 37% Evaluating, Examining, and Diagnosing, and 3% Professionalism. Nearly every stem ends with a decision: adjust the medication or reassure? Assess intensity or add minutes? Practicing those decisions beats re-reading pathophysiology chapters every time.
What does an 8-week plan look like?
| Weeks | Focus | Done when… |
|---|---|---|
| 1 | Baseline simulator (untimed); map your per-domain scores | You know exactly where your weak domains are |
| 2–4 | Treatment (60%): lifestyle prescription, pharmacotherapy thresholds and adjustments, bariatric surgery and post-op care | Treatment blocks score ≥75% |
| 5–6 | Evaluation and diagnosis (37%): staging, comorbidity workup, secondary causes of weight gain | No domain sits below 70% |
| 7 | Professionalism (3%) plus a sweep of every flagged weak spot | Your miss log is shrinking, not growing |
| 8 | Two timed full-length simulators; review every miss and every lucky guess | Stable timed scores with time to spare in each block |
Which habits separate passes from fails?
- Time every block. 72 seconds per question is comfortable until a dense metabolic vignette lands at question 45 of a block.
- Ask “is this response on target?” first. The 5%-at-3-months pharmacotherapy benchmark and its cousins decide a surprising share of treatment items.
- Read rationales even when you are right. Guideline thresholds (AACE/ACE, ADA/EASD) recur; the rationale is where you memorize them in context.
- Respect the 37%. Evaluation questions are quicker points than treatment questions — do not let the big domain crowd them out entirely.
- Use the breaks. Four blocks with up to 35 minutes of break time is a marathon format; rehearse it at least twice before test day.
What should I use to practice?
A bank with vignette-style questions, guideline-based rationales, and enough volume to stay fresh: ours is 3 ABOM simulators (600 questions) weighted to the blueprint above, $19.99 for lifetime access, with a free simulator to baseline first.
Unlock 600 ABOM practice questions across 3 full-length simulators — $19.99 lifetime →
Short on time? The ABOM cheat sheet is the one-page version, and the free practice questions take five minutes.
Free practice test · no signup
This is the level you are preparing for
A study plan only helps if you know the target. These are 5 real ABOM questions at exam level, with rationales.
5 free sample questions · full bank in the course
A 7-year-old boy presents with early-onset obesity (BMI 97th percentile since age 4) and developmental delay in motor skills. His parents report increasing difficulty with night vision over the past year. Physical examination reveals postaxial polydactyly on both hands. Renal ultrasound, ordered due to parental concerns, shows mild echogenic kidneys. The physician is concerned about a syndromic cause of obesity requiring prompt intervention due to potential renal complications. Based on the constellation of findings, which genetic syndrome is most likely?
Reveal answer & explanation
✓ Correct: C Bardet-Biedl syndrome
Why. Correct: Bardet-Biedl syndrome (BBS) is correct due to the core features: early-onset obesity, rod-cone dystrophy (presenting as night vision difficulty), postaxial polydactyly, and renal anomalies (echogenic kidneys). Developmental delay is also common. Prompt concern for renal complications aligns with BBS management priorities. Option A (Prader-Willi) is incorrect because it typically presents with neonatal hypotonia, feeding difficulties, hyperphagia emerging later, and lacks polydactyly or early retinal dystrophy. Option B (Alström) is incorrect as it features sensorineural deafness and cardiomyopathy, neither reported here, and polydactyly is not typical. Option D (MC4R deficiency) is incorrect as it causes hyperphagia-driven obesity without structural anomalies like polydactyly, renal issues, or retinal dystrophy. The discriminating cues (night vision loss, polydactyly, renal findings) specifically point to BBS.
A 58-year-old male with obesity (BMI 37 kg/m²), hypertension (BP 148/92 mm Hg on lisinopril 20mg daily), and prediabetes (HbA1c 6.0%) presents for initial obesity management. During the nutrition history, he reports consuming canned soups daily for lunch, frozen dinners 4 nights/week, and 2-3 regular sodas per day. He expresses willingness to change but feels overwhelmed. Based on prioritizing the most urgent dietary modification to address his specific cardiometabolic risks *first*, which intervention is most appropriate?
Reveal answer & explanation
✓ Correct: B Recommend switching from processed meals to home-cooked meals using fresh ingredients to reduce sodium.
Why. Correct: Option B is correct because uncontrolled hypertension (BP 148/92 mm Hg despite medication) poses the most immediate cardiovascular risk. Canned soups and frozen dinners are notoriously high in sodium, directly exacerbating hypertension. Reducing sodium intake is a guideline-recommended first-line dietary intervention (per JNC-8) in this context. Option A (eliminating sugary drinks) addresses prediabetes but is less urgent than uncontrolled hypertension; eliminating them completely may also be unsustainable initially. Option C (general calorie reduction) ignores the specific, high-risk sodium issue and lacks focus. Option D (switching to diet soda) reduces sugar but fails to address the critical sodium load from processed foods and doesn’t eliminate artificial sweetener concerns. Prioritizing sodium reduction targets the most pressing risk effectively.
A 42-year-old woman presents for obesity management. Her weight history reveals a baseline weight of 150 lbs (BMI 24) until age 26. She gained 35 lbs with her first pregnancy at age 27, retaining 15 lbs postpartum. At age 32, a second pregnancy led to a 40-lb gain, with 20 lbs retained. Since age 32, her weight has gradually increased by 1-2 lbs annually to her current 205 lbs (BMI 33). She reports stable dietary habits since her 20s, a sedentary office job starting at age 30, and well-controlled hypothyroidism on levothyroxine since age 28. Both parents have obesity. Based on her weight trajectory, which factor is the *most significant prior contributor* to her current weight status?
Reveal answer & explanation
✓ Correct: D Weight retention following each pregnancy
Why. Correct: The most significant contributor is the substantial weight retained after each pregnancy (Option D). Each pregnancy resulted in significant weight retention (15 lbs and 20 lbs), creating stepwise increases that established a new, higher baseline each time. This pattern aligns with evidence linking pregnancy-related weight retention to long-term obesity risk. The sedentary job (Option A) began after the first major weight increase and correlates with only gradual annual gain, not the pivotal jumps. While family history (Option B) confers risk, her stable baseline weight until age 26 suggests it wasn’t the primary driver of the documented increases. Hypothyroidism (Option C) was diagnosed and well-controlled *before* the pregnancies and major weight gains, making it an unlikely primary contributor to the subsequent stepwise increases. The timeline clearly implicates pregnancy-related retention as the dominant factor altering her weight trajectory.
A 58-year-old woman with a BMI of 38 kg/m², type 2 diabetes (HbA1c 7.2% on metformin), and hypertension presents for obesity management. Her physical exam reveals central adiposity and acanthosis nigricans. Routine blood work shows ALT 48 U/L (normal
Reveal answer & explanation
✓ Correct: C Refer to gastroenterology for further evaluation of non-alcoholic steatohepatitis (NASH) and fibrosis staging.
Why. Correct: This patient has multiple risk factors for advanced liver disease (obesity, diabetes, hypertension, elevated ALT, acanthosis) and an intermediate FIB-4 score (1.8), suggesting possible significant fibrosis (F2-F3). Current guidelines (AASLD) recommend further assessment for fibrosis in high-risk patients with intermediate/high non-invasive test scores, typically involving specialized tests like elastography or referral for possible biopsy. Option A delays necessary evaluation in a high-risk patient. Option B addresses weight and diabetes but ignores the specific liver disease severity indicated by FIB-4. Option D (ultrasound) confirms steatosis but cannot reliably stage fibrosis, which is the critical issue raised by the FIB-4. Referral (C) is essential for definitive staging and management decisions in suspected advanced NASH.
A 45-year-old woman with class 2 obesity (BMI 38 kg/m²), hypertension controlled on lisinopril 20mg daily, and major depressive disorder well-managed on sertraline 100mg daily presents for obesity management. She reports consistent motivation but expresses significant concern about medication-induced weight gain. Her blood pressure today is 128/82 mmHg. Based on current guidelines for treating obesity as a complex chronic disease, which anti-obesity medication is the MOST appropriate initial pharmacotherapy considering her comorbidities and expressed concern?
Reveal answer & explanation
✓ Correct: D Phentermine-Topiramate ER
Why. Correct: Phentermine-Topiramate ER (D) is the most appropriate choice. Guidelines prioritize medications with the highest efficacy for significant weight loss in Class 2/3 obesity, and Phentermine-Topiramate ER demonstrates superior weight loss efficacy compared to Orlistat (C) or Naltrexone-Bupropion (A) in this BMI range. While Liraglutide (B) is effective, Phentermine-Topiramate ER typically achieves greater absolute weight reduction. Crucially, the patient’s controlled hypertension allows cautious use of phentermine (monitor BP), and topiramate may offer mood-stabilizing benefits without interfering with sertraline. Naltrexone-Bupropion (A) is contraindicated due to uncontrolled hypertension risk from bupropion’s noradrenergic effects, despite potential mood benefits. Orlistat (C) has modest efficacy and gastrointestinal side effects, making it less ideal as first-line for significant weight loss needs. Liraglutide (B) is effective but generally shows slightly lower average weight loss than Phentermine-Topiramate ER in higher BMI classes and doesn’t specifically address her depression comorbidity synergistically. Phentermine-Topiramate ER best balances high efficacy, safety with controlled hypertension, and potential adjunctive benefit for mood without causing weight gain.
Frequently asked questions
How long does it take to prepare for the ABOM exam?
About 8 weeks at a few hours per week for a physician already seeing patients with obesity. Extend toward 12 weeks if obesity medicine is not part of your daily practice.
What is the best way to study for the ABOM exam?
Question-first: baseline yourself, spend the majority of your hours on the Treatment domain (60% of scoring), sweep evaluation and diagnosis (37%), then finish with timed full-length simulators, reviewing every rationale.
When should I apply for the ABOM exam?
By the early deadline (July 10) to pay $1,500 instead of $1,750 — the exam itself is administered each October at Pearson VUE centers.
Do I need a fellowship to sit for the ABOM exam?
No. Most candidates qualify through the CME pathway: 60 obesity CME credits including 30 ABOM-designated Group One credits, alongside licensure, residency, and active ABMS board certification. A fellowship pathway also exists.
Sources & references
The exam facts on this page are drawn from official certifying-body materials, reviewed 2026-06-18 by the DrCertifications exam-prep team (10+ years in exam preparation and publishing).